Skip to main content
Market intelligence
RXSTHealthcare

RxSight Inc insider activity

In the last 90 days, no corporate insiders reported open-market purchases.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
0
90-day purchase value
$0.00
Corporate buyers
0
Latest transaction
Sep 2, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
Sep 2, 2026Ronald M Md KurtzChief Medical OfficerSale5,100$6.96$35,496
Sep 2, 2026Mark WilterdingChief Financial OfficerSale7,765$6.96$54,044
Sep 2, 2026Ilya GoldshlegerChief Operating OfficerSale2,041$6.96$14,205